MEDIFAST (MED)
(Delayed Data from NYSE)
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Lamb Weston (LW) Q1 Earnings Top Estimates, Sales Fall Y/Y
by Zacks Equity Research
Lamb Weston's (LW) first-quarter fiscal 2021 results reflect lower earnings and sales due to soft demand in foodservice channel and elevated costs associated with COVID-19.
McCormick (MKC) Looks Poised on High Demand, Saving Efforts
by Zacks Equity Research
McCormick (MKC) is on track with the CCI program to boost savings. However, sluggish performance in its Flavor Solution Unit is a concern.
5 Top DuPont-Driven Stocks to Counter Stimulus Uncertainty
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Zacks.com featured highlights include: Zumiez, Installed Building Products, 1-800-FLOWERS.COM, Medifast and Nu Skin
by Zacks Equity Research
Zacks.com featured highlights include: Zumiez, Installed Building Products, 1-800-FLOWERS.COM, Medifast and Nu Skin
Bet on These 5 Top-Ranked Liquid Stocks for Fat Returns
by Radhika Pujara
Here are five top-ranked liquid stocks, including Nu Skin Enterprises (NUS), that investors can snap up for enhancing portfolio returns.
McCormick's (MKC) Q3 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
McCormick's (MKC) third-quarter fiscal 2020 results reflect the impact of higher sales driven by greater at-home consumption amid the pandemic.
General Mills (GIS) Q1 Earnings & Sales Top Estimates, Up Y/Y
by Zacks Equity Research
General Mills' (GIS) first-quarter fiscal 2021 results reflect improved earnings and sales due to rising demand stemming from increased at-home consumption amid the pandemic.
Is MEDIFAST INC (MED) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
5 DuPont-Rich Quality Picks to Handle Sudden Sell-Off
by Sanghamitra Saha
Why you should depend on the DuPont technique to pick solid profit-generating stocks.
The Zacks Analyst Blog Highlights: Target, Medifast, The Scotts Miracle-Gro, Griffon Corp and Stewart Information Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Target, Medifast, The Scotts Miracle-Gro, Griffon Corp and Stewart Information Services
4 Promising Top-Ranked Liquid Stocks to Enrich Your Portfolio
by Radhika Pujara
Here are four top-ranked liquid stocks, including Zumiez (ZUMZ), that investors can bank on for alluring returns.
4 Reasons Why Flowers Foods (FLO) Stock is Worth Relishing
by Zacks Equity Research
Flowers Foods (FLO) is gaining on rising demand amid the pandemic-led higher at-home consumption. The company is also poised to benefit from focus on core strategies.
The Zacks Analyst Blog Highlights: Virtusa, RH, M/I Homes, Mr. Cooper Group and Medifast
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Virtusa, RH, M/I Homes, Mr. Cooper Group and Medifast
5 Top-Ranked High-Yielding Growth Stocks for September
by Nalak Das
Volatility may persist for a few more days. However, the worst of Wall Street is long over and the overall market movement should remain positive going forward.
Favorable Demand Keeps Campbell Soup Afloat Amid Cost Woes
by Zacks Equity Research
Increasing at-home consumption is boosting Campbell Soup's (CPB) sales. However COVID-19 related costs are a burden.
6 Top-Ranked Stocks That Surged More Than 10% Last Week
by Nalak Das
Several stocks skyrocketed last week and a handful of these were Zacks top-ranked.
Nomad Foods (NOMD) Catches Eye: Stock Jumps 5.9%
by Zacks Equity Research
Nomad Foods (NOMD) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Nomad Foods (NOMD) Catches Eye: Stock Jumps 5.9%
by Zacks Equity Research
Nomad Foods (NOMD) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Hain Celestial Gaining, North America Unit a Key Catalyst
by Zacks Equity Research
Hain Celestial's (HAIN) North America unit is performing well on the back of Get Bigger brands. Further, the company is on track with transformation plans.
Zacks.com featured highlights include: MED, JD, HUM, UFPI and EXPD
by Zacks Equity Research
Zacks.com featured highlights include: MED, JD, HUM, UFPI and EXPD
Hershey (HSY) Looks Poised on Brand Strength, Pricing Efforts
by Zacks Equity Research
Hershey's (HSY) brands are gaining on focus on innovation and buyouts. Also, the company is seeing sales growth in North America amid the pandemic.
Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
5 Top-Ranked Stocks Picked on DuPont Analysis
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
MGP Ingredients (MGPI) Looks Good: Stock Adds 5.4% in Session
by Zacks Equity Research
MGP Ingredients (MGPI) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Here is Why Growth Investors Should Buy Medifast (MED) Now
by Zacks Equity Research
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.